Title : A phase 1 trial evaluating thioridazine in combination with cytarabine in patients with acute myeloid leukemia.

Pub. Date : 2018 Aug 14

PMID : 30093531






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We completed a phase 1 dose-escalation trial to evaluate the safety of a dopamine receptor D2 (DRD2) antagonist thioridazine (TDZ), in combination with cytarabine. Thioridazine dopamine receptor D2 Homo sapiens
2 We completed a phase 1 dose-escalation trial to evaluate the safety of a dopamine receptor D2 (DRD2) antagonist thioridazine (TDZ), in combination with cytarabine. Thioridazine dopamine receptor D2 Homo sapiens
3 We completed a phase 1 dose-escalation trial to evaluate the safety of a dopamine receptor D2 (DRD2) antagonist thioridazine (TDZ), in combination with cytarabine. Thioridazine dopamine receptor D2 Homo sapiens